首页> 美国卫生研究院文献>Vaccines >Animal Models Utilized for the Development of Influenza Virus Vaccines
【2h】

Animal Models Utilized for the Development of Influenza Virus Vaccines

机译:用于开发流感病毒疫苗的动物模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Animal models have been an important tool for the development of influenza virus vaccines since the 1940s. Over the past 80 years, influenza virus vaccines have evolved into more complex formulations, including trivalent and quadrivalent inactivated vaccines, live-attenuated vaccines, and subunit vaccines. However, annual effectiveness data shows that current vaccines have varying levels of protection that range between 40–60% and must be reformulated every few years to combat antigenic drift. To address these issues, novel influenza virus vaccines are currently in development. These vaccines rely heavily on animal models to determine efficacy and immunogenicity. In this review, we describe seasonal and novel influenza virus vaccines and highlight important animal models used to develop them.
机译:动物模型是自20世纪40年代以来发展流感病毒疫苗的重要工具。在过去的80年中,流感病毒疫苗已经进化成更复杂的制剂,包括三价和四肢灭活疫苗,活衰减疫苗和亚基疫苗。然而,年度有效性数据表明,目前的疫苗具有不同水平的保护水平,范围在40-60%之间,必须每隔几年重新重整以打击抗原漂移。为了解决这些问题,目前新的流感病毒疫苗目前正在开发中。这些疫苗严重依赖于动物模型来确定疗效和免疫原性。在这篇综述中,我们描述了季节性和新的流感病毒疫苗,并突出了用于开发它们的重要动物模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号